Literature DB >> 19337983

KHSV(-) EBV(-) post-transplant effusion lymphoma with plasmablastic features: variant of primary effusion lymphoma?

Jennifer S Lambe1, Darryl A Oble, Subhadra V Nandula, Deborah W Sevilla, Adriana I Colovai, Mahesh Mansukhani, Ajai Chari, Vundavalli V Murty, Bachir Alobeid, Govind Bhagat.   

Abstract

Primary effusion lymphoma (PEL) is a rare type of B-cell non-Hodgkin lymphoma (NHL), which predominantly occurs in HIV-infected individuals, and is pathogenetically linked with Kaposi sarcoma (KS)-associated herpes virus/human herpes virus-8 (KSHV/HHV-8) infection with or without evidence of Epstein-Barr virus (EBV) co-infection. Although uncommon, PELs have been reported in immunocompetent patients and recipients of solid organ allografts. Rare cases of KSHV(-) EBV(+) post-transplant effusion lymphomas resembling PEL have also been described, as have KSHV(-) EBV(-) effusion lymphomas, the latter including those arising in individuals with chronic liver disease. We report a unique KSHV(-) EBV(-) post-transplant effusion lymphoma associated with serum paraproteins, occurring in an HIV(-) individual, which had cytologic features and phenotype similar to PEL, and displayed a complex karyotype including isochromosome 12p and translocation t(8;22), resulting in rearrangement of c-MYC. Copyright (c) 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2009        PMID: 19337983     DOI: 10.1002/hon.892

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN: 0278-0232            Impact factor:   5.271


  1 in total

1.  Posttransplant Lymphoproliferative Disorder in a Patient with Worsening Ascites after Liver Transplantation.

Authors:  Harsh D Patel; Moises I Nevah Rubin
Journal:  Case Rep Hematol       Date:  2017-09-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.